AHR and cancer: These results were supported by Dononi et al. [19], who recently reported that the mRNA and protein expression of AhR and G-protein coupled receptor 30 (GPR30), both markers of poor prognosis in cancer patients [60,61], were concomitantly expressed following low-dose chronic exposure to B[a]P in these premalignant cells.